Our results demonstrate that CPE prevents endothelial dysfunction by normalizing the vasoactive/vasoconstrictive state in the kidney, modulating the expression of AT1R and AT2R/Mas1 and allowing for NO production. The gene discussed is AGTR1; the disease is endothelial dysfunction.